Uranium Energy Valuation

Is U6Z undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of U6Z when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: U6Z (€6.15) is trading above our estimate of fair value (€5.55)

Significantly Below Fair Value: U6Z is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for U6Z?

Other financial metrics that can be useful for relative valuation.

U6Z key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue11931.7x
Enterprise Value/EBITDA-49.3x
PEG Ration/a

Price to Book Ratio vs Peers

How does U6Z's PB Ratio compare to its peers?

The above table shows the PB ratio for U6Z vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average1.7x
ETG EnviTec Biogas
2.7xn/a€458.9m
VBK Verbio
1.2x34.2%€1.1b
CE2 CropEnergies
1.3x-7.5%€1.0b
CE2 CropEnergies
1.8xn/a€1.2b
U6Z Uranium Energy
3.6x-6.1%€2.8b

Price-To-Book vs Peers: U6Z is expensive based on its Price-To-Book Ratio (3.6x) compared to the peer average (1.7x).


Price to Earnings Ratio vs Industry

How does U6Z's PE Ratio compare vs other companies in the European Oil and Gas Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a0.7%
n/an/an/a
No. of CompaniesPB048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a0.7%
n/an/an/a
No more companies

Price-To-Book vs Industry: U6Z is expensive based on its Price-To-Book Ratio (3.6x) compared to the European Oil and Gas industry average (0.9x).


Price to Book Ratio vs Fair Ratio

What is U6Z's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

U6Z PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio3.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate U6Z's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst U6Z forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€6.34
€9.49
+49.7%
11.2%€11.77€8.60n/a6
Oct ’25€5.82
€9.42
+61.9%
11.2%€11.68€8.54n/a6
Sep ’25€4.62
€9.31
+101.7%
11.9%€11.80€8.17n/a7
Aug ’25€4.96
€9.58
+93.3%
11.9%€12.15€8.41n/a7
Jul ’25€5.43
€9.58
+76.6%
11.9%€12.15€8.41n/a7
Jun ’25€6.69
€9.68
+44.7%
11.2%€12.14€8.41n/a7
May ’25€6.36
€9.68
+52.1%
11.2%€12.14€8.41n/a7
Apr ’25€6.35
€9.56
+50.6%
11.2%€12.03€8.33n/a7
Mar ’25€6.38
€9.54
+49.7%
11.4%€12.01€8.32n/a7
Feb ’25€7.51
€8.91
+18.6%
19.9%€11.96€6.07n/a6
Jan ’25€5.84
€6.77
+15.9%
10.2%€7.87€6.02n/a7
Dec ’24€6.06
€6.42
+6.0%
7.8%€7.58€5.98n/a7
Nov ’24€5.61
€6.55
+16.7%
6.6%€7.54€6.13n/a7
Oct ’24€4.96
€6.24
+25.9%
9.5%€7.45€5.59€5.827
Sep ’24€4.09
€6.28
+53.6%
9.0%€7.38€5.53€4.626
Aug ’24€3.29
€6.12
+86.2%
9.0%€7.18€5.39€4.966
Jul ’24€3.11
€6.36
+104.6%
9.0%€7.43€5.57€5.436
Jun ’24€2.73
€6.36
+133.3%
9.0%€7.43€5.57€6.696
May ’24€2.36
€6.25
+165.0%
11.0%€7.53€5.25€6.366
Apr ’24€2.71
€6.42
+136.9%
11.0%€7.74€5.39€6.356
Mar ’24€3.46
€6.42
+85.6%
10.1%€7.69€5.59€6.386
Feb ’24€3.63
€6.33
+74.5%
10.1%€7.58€5.51€7.516
Jan ’24€3.52
€6.47
+83.7%
11.1%€7.77€5.65€5.845
Dec ’23€3.60
€7.08
+96.6%
10.2%€8.44€6.40€6.065
Nov ’23€4.29
€7.08
+65.2%
10.2%€8.44€6.40€5.615
Oct ’23€3.75
€6.57
+75.1%
7.8%€7.25€6.00€4.965

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies